Antifungal Drugs Market (2026 - 2033) Size, Share & Trends Analysis Report By Drug Class (Azoles, Polyenes, Allylamines, Echinocandins), By Indication, By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Drug Class
                        1.2.2. Indication
                        1.2.3. Dosage Form
                        1.2.4. Distribution Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Antifungal Drugs Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. Antifungal Drugs Market: Drug Class Business Analysis
                    4.1. Drug Class Market Share, 2025 & 2033
                    4.2. Drug Class Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
                    4.4. Azoles
                        4.4.1. Azoles Market, 2021 - 2033 (USD Billion)
                    4.5. Echinocandins
                        4.5.1. Echinocandins Market, 2021 - 2033 (USD Billion)
                    4.6. Polyenes
                        4.6.1. Polyenes Market, 2021 - 2033 (USD Billion)
                    4.7. Allylamines
                        4.7.1. Allylamines Market, 2021 - 2033 (USD Billion)
                    4.8. Others
                        4.8.1. Other Drug Class Market, 2021 - 2033 (USD Billion)
Chapter 5. Antifungal Drugs Market: Indication Business Analysis
                    5.1. Indication Market Share, 2025 & 2033
                    5.2. Indication Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Billion)
                    5.4. Dermatophytosis
                        5.4.1. Dermatophytosis Market, 2021 - 2033 (USD Billion)
                    5.5. Aspergillosis
                        5.5.1. Aspergillosis Market, 2021 - 2033 (USD Billion)
                    5.6. Candidiasis
                        5.6.1. Candidiasis Market, 2021 - 2033 (USD Billion)
                    5.7. Others
                        5.7.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 6. Antifungal Drugs Market: Dosage Form Business Analysis
                    6.1. Dosage Form Market Share, 2025 & 2033
                    6.2. Dosage Form Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2021 to 2033 (USD Billion)
                    6.4. Oral Drugs
                        6.4.1. Oral Drugs Market, 2021 - 2033 (USD Billion)
                    6.5. Ointments
                        6.5.1. Ointments Market, 2021 - 2033 (USD Billion)
                    6.6. Powders
                        6.6.1. Powders Market, 2021 - 2033 (USD Billion)
                    6.7. Others
                        6.7.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 7. Antifungal Drugs Market: Distribution Channel Business Analysis
                    7.1. Distribution Channel Market Share, 2025 & 2033
                    7.2. Distribution Channel Segment Dashboard
                    7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
                    7.4. Hospital Pharmacies
                        7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
                    7.5. Retail Pharmacies
                        7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
                    7.6. Other Pharmacies
                        7.6.1. Other Pharmacies Market, 2021 - 2033 (USD Billion)
Chapter 8. Antifungal Drugs Market: Regional Estimates & Trend Analysis
                    8.1. Regional Market Share Analysis, 2025 & 2033
                    8.2. Regional Market Dashboard
                    8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    8.4. North America
                        8.4.1. North America Antifungal Drugs Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
                        8.4.2. U.S.
                            8.4.2.1. Key Country Dynamics
                            8.4.2.2. Target Disease Prevalence
                            8.4.2.3. Regulatory Framework
                            8.4.2.4. Reimbursement Framework
                            8.4.2.5. U.S. Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.4.3. Canada
                            8.4.3.1. Key Country Dynamics
                            8.4.3.2. Target Disease Prevalence
                            8.4.3.3. Regulatory Framework
                            8.4.3.4. Reimbursement Framework
                            8.4.3.5. U.S. Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.4.4. Mexico
                            8.4.4.1. Key Country Dynamics
                            8.4.4.2. Target Disease Prevalence
                            8.4.4.3. Regulatory Framework
                            8.4.4.4. Reimbursement Framework
                            8.4.4.5. Mexico Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    8.5. Europe
                        8.5.1. Europe Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.2. UK
                            8.5.2.1. Key Country Dynamics
                            8.5.2.2. Target Disease Prevalence
                            8.5.2.3. Regulatory Framework
                            8.5.2.4. Reimbursement Framework
                            8.5.2.5. UK Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.3. Germany
                            8.5.3.1. Key Country Dynamics
                            8.5.3.2. Target Disease Prevalence
                            8.5.3.3. Regulatory Framework
                            8.5.3.4. Reimbursement Framework
                            8.5.3.5. Germany Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.4. France
                            8.5.4.1. Key Country Dynamics
                            8.5.4.2. Target Disease Prevalence
                            8.5.4.3. Regulatory Framework
                            8.5.4.4. Reimbursement Framework
                            8.5.4.5. France Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.5. Italy
                            8.5.5.1. Key Country Dynamics
                            8.5.5.2. Target Disease Prevalence
                            8.5.5.3. Regulatory Framework
                            8.5.5.4. Reimbursement Framework
                            8.5.5.5. Italy Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.6. Spain
                            8.5.6.1. Key Country Dynamics
                            8.5.6.2. Target Disease Prevalence
                            8.5.6.3. Regulatory Framework
                            8.5.6.4. Reimbursement Framework
                            8.5.6.5. Spain Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.7. Denmark
                            8.5.7.1. Key Country Dynamics
                            8.5.7.2. Target Disease Prevalence
                            8.5.7.3. Regulatory Framework
                            8.5.7.4. Reimbursement Framework
                            8.5.7.5. Denmark Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.8. Sweden
                            8.5.8.1. Key Country Dynamics
                            8.5.8.2. Target Disease Prevalence
                            8.5.8.3. Regulatory Framework
                            8.5.8.4. Reimbursement Framework
                            8.5.8.5. Sweden Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.5.9. Norway
                            8.5.9.1. Key Country Dynamics
                            8.5.9.2. Target Disease Prevalence
                            8.5.9.3. Regulatory Framework
                            8.5.9.4. Reimbursement Framework
                            8.5.9.5. Norway Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    8.6. Asia Pacific
                        8.6.1. Asia Pacific Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.2. Japan
                            8.6.2.1. Key Country Dynamics
                            8.6.2.2. Target Disease Prevalence
                            8.6.2.3. Regulatory Framework
                            8.6.2.4. Reimbursement Framework
                            8.6.2.5. Japan Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.3. China
                            8.6.3.1. Key Country Dynamics
                            8.6.3.2. Target Disease Prevalence
                            8.6.3.3. Regulatory Framework
                            8.6.3.4. Reimbursement Framework
                            8.6.3.5. China Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.4. India
                            8.6.4.1. Key Country Dynamics
                            8.6.4.2. Target Disease Prevalence
                            8.6.4.3. Regulatory Framework
                            8.6.4.4. Reimbursement Framework
                            8.6.4.5. India Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.5. Australia
                            8.6.5.1. Key Country Dynamics
                            8.6.5.2. Target Disease Prevalence
                            8.6.5.3. Regulatory Framework
                            8.6.5.4. Reimbursement Framework
                            8.6.5.5. Australia Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.6. South Korea
                            8.6.6.1. Key Country Dynamics
                            8.6.6.2. Target Disease Prevalence
                            8.6.6.3. Regulatory Framework
                            8.6.6.4. Reimbursement Framework
                            8.6.6.5. South Korea Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.6.7. Thailand
                            8.6.7.1. Key Country Dynamics
                            8.6.7.2. Target Disease Prevalence
                            8.6.7.3. Regulatory Framework
                            8.6.7.4. Reimbursement Framework
                            8.6.7.5. Thailand Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    8.7. Latin America
                        8.7.1. Latin America Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.7.2. Brazil
                            8.7.2.1. Key Country Dynamics
                            8.7.2.2. Target Disease Prevalence
                            8.7.2.3. Regulatory Framework
                            8.7.2.4. Reimbursement Framework
                            8.7.2.5. Brazil Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.7.3. Argentina
                            8.7.3.1. Key Country Dynamics
                            8.7.3.2. Target Disease Prevalence
                            8.7.3.3. Regulatory Framework
                            8.7.3.4. Reimbursement Framework
                            8.7.3.5. Argentina Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    8.8. Middle East and Africa
                        8.8.1. Middle East and Africa Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.8.2. South Africa
                            8.8.2.1. Key Country Dynamics
                            8.8.2.2. Target Disease Prevalence
                            8.8.2.3. Regulatory Framework
                            8.8.2.4. Reimbursement Framework
                            8.8.2.5. South Africa Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.8.3. Saudi Arabia
                            8.8.3.1. Key Country Dynamics
                            8.8.3.2. Target Disease Prevalence
                            8.8.3.3. Regulatory Framework
                            8.8.3.4. Reimbursement Framework
                            8.8.3.5. Saudi Arabia Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.8.4. UAE
                            8.8.4.1. Key Country Dynamics
                            8.8.4.2. Target Disease Prevalence
                            8.8.4.3. Regulatory Framework
                            8.8.4.4. Reimbursement Framework
                            8.8.4.5. UAE Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                        8.8.5. Kuwait
                            8.8.5.1. Key Country Dynamics
                            8.8.5.2. Target Disease Prevalence
                            8.8.5.3. Regulatory Framework
                            8.8.5.4. Reimbursement Framework
                            8.8.5.5. Kuwait Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
                    9.1. Participant Overview
                    9.2. Company Market Position Analysis
                    9.3. Company Categorization
                    9.4. Strategy Mapping
                    9.5. Company Profiles/Listing
                        9.5.1. Bausch Health Companies Inc.
                            9.5.1.1. Overview
                            9.5.1.2. Financial Performance
                            9.5.1.3. Product Benchmarking
                            9.5.1.4. Strategic Initiatives
                        9.5.2. Pfizer, Inc.
                            9.5.2.1. Overview
                            9.5.2.2. Financial Performance
                            9.5.2.3. Product Benchmarking
                            9.5.2.4. Strategic Initiatives
                        9.5.3. Bayer AG
                            9.5.3.1. Overview
                            9.5.3.2. Financial Performance
                            9.5.3.3. Product Benchmarking
                            9.5.3.4. Strategic Initiatives
                        9.5.4. Sandoz
                            9.5.4.1. Overview
                            9.5.4.2. Financial Performance
                            9.5.4.3. Product Benchmarking
                            9.5.4.4. Strategic Initiatives
                        9.5.5. Merck & Co., Inc.
                            9.5.5.1. Overview
                            9.5.5.2. Financial Performance
                            9.5.5.3. Product Benchmarking
                            9.5.5.4. Strategic Initiatives
                        9.5.6. GSK plc.
                            9.5.6.1. Overview
                            9.5.6.2. Financial Performance
                            9.5.6.3. Product Benchmarking
                            9.5.6.4. Strategic Initiatives
                        9.5.7. Kenvue
                            9.5.7.1. Overview
                            9.5.7.2. Financial Performance
                            9.5.7.3. Product Benchmarking
                            9.5.7.4. Strategic Initiatives
                        9.5.8. GLENMARK
                            9.5.8.1. Overview
                            9.5.8.2. Financial Performance
                            9.5.8.3. Product Benchmarking
                            9.5.8.4. Strategic Initiatives
                        9.5.9. Janssen Pharmaceuticals
                            9.5.9.1. Overview
                            9.5.9.2. Financial Performance
                            9.5.9.3. Product Benchmarking
                            9.5.9.4. Strategic Initiatives
                        9.5.10. Astellas Pharma, Inc.
                            9.5.10.1. Overview
                            9.5.10.2. Financial Performance
                            9.5.10.3. Product Benchmarking
                            9.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Antifungal drugs market, by region, 2021 - 2033 (USD Billion)
Table 4 Global antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 5 Global antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 6 Global antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 7 Global antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 8 North America antifungal drugs market, by country, 2021 - 2033 (USD Billion)
Table 9 North America antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 10 North America antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 11 North America antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 12 North America antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 13 US antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 14 US antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 15 US antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 16 US antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 17 Canada antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 18 Canada antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 19 Canada antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 20 Canada antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 21 Mexico antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 22 Mexico antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 23 Mexico antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 24 Mexico antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 25 Europe antifungal drugs market, by country, 2021 - 2033 (USD Billion)
Table 26 Europe antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 27 Europe antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 28 Europe antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 29 Europe antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 30 UK antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 31 UK antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 32 UK antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 33 UK antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 34 Germany antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 35 Germany antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 36 Germany antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 37 Germany antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 38 France antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 39 France antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 40 France antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 41 France antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 42 Italy antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 43 Italy antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 44 Italy antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 45 Italy antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 46 Spain antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 47 Spain antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 48 Spain antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 49 Spain antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 50 Norway antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 51 Norway antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 52 Norway antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 53 Norway antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 54 Denmark antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 55 Denmark antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 56 Denmark antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 57 Denmark antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 58 Sweden antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 59 Sweden antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 60 Sweden antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 61 Sweden antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 62 Asia Pacific antifungal drugs market, by country, 2021 - 2033 (USD Billion)
Table 63 Asia Pacific antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 64 Asia Pacific antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 65 Asia Pacific antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 66 Asia Pacific antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 67 Japan antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 68 Japan antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 69 Japan antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 70 Japan antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 71 China antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 72 China antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 73 China antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 74 China antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 75 India antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 76 India antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 77 India antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 78 India antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 79 Australia antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 80 Australia antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 81 Australia antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 82 Australia antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 83 South Korea antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 84 South Korea antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 85 South Korea antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 86 South Korea antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 87 Thailand antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 88 Thailand antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 89 Thailand antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 90 Thailand antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 91 Latin America antifungal drugs market, by country, 2021 - 2033 (USD Billion)
Table 92 Latin America antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 93 Latin America antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 94 Latin America antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 95 Latin America antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 96 Brazil antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 97 Brazil antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 98 Brazil antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 99 Brazil antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 100 Argentina antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 101 Argentina antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 102 Argentina antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 103 Argentina antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 104 Middle East & Africa antifungal drugs market, by country, 2021 - 2033 (USD Billion)
Table 105 Middle East & Africa antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 106 Middle East & Africa antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 107 Middle East & Africa antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 108 Middle East & Africa antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 109 South Africa antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 110 South Africa antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 111 South Africa antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 112 South Africa antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 113 Saudi Arabia antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 115 Saudi Arabia antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 116 Saudi Arabia antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 117 UAE antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 118 UAE antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 119 UAE antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 120 UAE antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
Table 121 Kuwait antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
Table 122 Kuwait antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
Table 123 Kuwait antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
Table 124 Kuwait antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 Antifungal drugs market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape
Fig. 11 Antifungal drugs market dynamics
Fig. 12 Antifungal drugs market: Porter’s five forces analysis
Fig. 13 Antifungal drugs market: PESTLE analysis
Fig. 14 Drug Class market, 2021 - 2033 (USD Billion)
Fig. 15 Azoles market, 2021 - 2033 (USD Billion)
Fig. 16 Echinocandins market, 2021 - 2033 (USD Billion)
Fig. 17 Polyenes market, 2021 - 2033 (USD Billion)
Fig. 18 Allylamines market, 2021 - 2033 (USD Billion)
Fig. 19 Others market, 2021 - 2033 (USD Billion)
Fig. 20 Indication market, 2021 - 2033 (USD Billion)
Fig. 21 Dermatophytosis market, 2021 - 2033 (USD Billion)
Fig. 22 Aspergillosis market, 2021 - 2033 (USD Billion)
Fig. 23 Candidiasis market, 2021 - 2033 (USD Billion)
Fig. 24 Others market, 2021 - 2033 (USD Billion)
Fig. 25 Dosage Form market, 2021 - 2033 (USD Billion)
Fig. 26 Oral Drugs market, 2021 - 2033 (USD Billion)
Fig. 27 Ointments market, 2021 - 2033 (USD Billion)
Fig. 28 Powders market, 2021 - 2033 (USD Billion)
Fig. 29 Others market, 2021 - 2033 (USD Billion)
Fig. 30 Distribution Channel market, 2021 - 2033 (USD Billion)
Fig. 31 Hospital pharmacies market, 2021 - 2033 (USD Billion)
Fig. 32 Retail pharmacies market, 2021 - 2033 (USD Billion)
Fig. 33 Other pharmacies market, 2021 - 2033 (USD Billion)
Fig. 34 Antifungal drugs market revenue, by region
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 North America antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 37 U.S. country dynamics
Fig. 38 U.S. antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 39 Canada country dynamics
Fig. 40 Canada antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 41 Mexico country dynamics
Fig. 42 Mexico antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 43 Europe antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 44 UK country dynamics
Fig. 45 UK antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 46 Germany country dynamics
Fig. 47 Germany antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 48 France country dynamics
Fig. 49 France antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 50 Italy country dynamics
Fig. 51 Italy antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 52 Spain country dynamics
Fig. 53 Spain antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 54 Norway country dynamics
Fig. 55 Norway antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 56 Sweden country dynamics
Fig. 57 Sweden antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 58 Denmark country dynamics
Fig. 59 Denmark antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 60 Asia Pacific antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 61 Japan country dynamics
Fig. 62 Japan antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 63 China country dynamics
Fig. 64 China antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 65 India country dynamics
Fig. 66 India antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 67 Australia country dynamics
Fig. 68 Australia antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 69 South Korea country dynamics
Fig. 70 South Korea antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 71 Thailand country dynamics
Fig. 72 Thailand antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 73 Latin America antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 74 Brazil country dynamics
Fig. 75 Brazil antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 76 Argentina country dynamics
Fig. 77 Argentina antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 78 MEA antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 79 South Africa country dynamics
Fig. 80 South Africa antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 81 Saudi Arabia country dynamics
Fig. 82 Saudi Arabia antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 83 UAE country dynamics
Fig. 84 UAE antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 85 Kuwait country dynamics
Fig. 86 Kuwait antifungal drugs market, 2021 - 2033 (USD Billion)
Fig. 87 Company categorization
Fig. 88 Company market position analysis, 2024
Fig. 89 Strategic framework